Once-Temporary Remote Inspection Tools Are Now Part of Everyday Regulatory Life

The COVID-19 public health emergency may be officially over, but the temporary changes it provoked in regulatory assessments are here to stay, experts said during the 18th Annual FDA Inspections Summit last week.
Source: Drug Industry Daily